Viral Vector Manufacturing (VVMF) enters into licensing agreement with OXB, gaining access to the OXB AAV and LV viral vector platforms

Viral Vector Manufacturing Facility Pty Ltd (VVMF), Australia’s first commercial viral vector Contract Development and Manufacturing Organisation (CDMO), today announces that it has entered into a ...
GEN

Viral Vector Industry Boosts Product Quality and Quantity

The viral vector and plasmid DNA manufacturing market is one of the fastest growing global biotechnology segments. Pegged at $321.3 million in 2017, the market is expected to reach $1.1 billion by ...
BioProcess International

Viral Vector Manufacturing Simplified: A Sponsor’s Guide to Smarter CDMO Partnerships

Accelerate CGT developement with strategic viral vector manufacturing and CDMO partnerships that balance quality, cost, and speed from bench to clinic.
Fred Hutch

Vector Production

As a lab within the Cooperative Center of Excellence in Hematology (CCEH) at Fred Hutch, the Vector Production core assists investigators with the design, construction, and/or production of viral ...
Nature

Comparative studies on cellular gene regulation by HIV-1 based vectors: implications for quality control of vector production

Among the recent gene therapy protocols, vectors that can stably express transgenes, for example, HIV-1-based vectors, are particularly desirable. There have been no direct reports on insertional ...